Industry Research Reports

Home > Reports > Chemical & Material > Tocilizumab- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Tocilizumab- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Chemical & Material

Published Date: 2026-07-14

Pages: 140 Pages

Report ld: 6893166

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Tocilizumab was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.

Tocilizumab is a humanized monoclonal antibody resistant against the interleukin-6 receptor (IL-6R). It is an immunosuppressive agent commonly used for the treatment of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis.

The North American market for Tocilizumab was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.

The Asia-Pacific market for Tocilizumab was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.

The European market for Tocilizumab was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.

The global key companies in the Tocilizumab market include Bio-Rad Laboratories, Bio-Techne, BioVision, Selleck Chemicals, Biorbyt, AbMole, Biosynth Carbosynth, SimSon Pharma, BOC Sciences, Clearsynth, etc. In 2025, the five largest players accounted for approximately % of revenue.

This report provides a comprehensive view of the global market for Tocilizumab, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Tocilizumab market size, estimations, and forecasts are presented in terms of sales volume (Kg) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Tocilizumab.

MARKET SEGMENTATION

By Company

Bio-Rad Laboratories
Bio-Techne
BioVision
Selleck Chemicals
Biorbyt
AbMole
Biosynth Carbosynth
SimSon Pharma
BOC Sciences
Clearsynth
LifeSpan BioSciences

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%

Segment by Application

Research
Medical

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.

Chapter 2: Provides a detailed analysis of the Tocilizumab manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Tocilizumab sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Tocilizumab sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.

Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Tocilizumab Product Introduction

1.2 Global Tocilizumab Market Size Forecast

1.2.1 Global Tocilizumab Sales Value (2021–2032)

1.2.2 Global Tocilizumab Sales Volume (2021–2032)

1.2.3 Global Tocilizumab Sales Price (2021–2032)

1.3 Tocilizumab Market Trends & Drivers

1.3.1 Tocilizumab Industry Trends

1.3.2 Tocilizumab Market Drivers & Opportunities

1.3.3 Tocilizumab Market Challenges

1.3.4 Tocilizumab Market Restraints

1.3.5 Impact of U.S. Tariffs

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Tocilizumab Players Revenue Ranking (2025)

2.2 Global Tocilizumab Revenue by Company (2021–2026)

2.3 Global Tocilizumab Sales Volume Ranking of Players (2025)

2.4 Global Tocilizumab Sales Volume by Company (2021–2026)

2.5 Global Tocilizumab Average Price by Company (2021–2026)

2.6 Key Manufacturers Tocilizumab Manufacturing Base and Headquarters

2.7 Key Manufacturers Tocilizumab Product Offerings

2.8 Key Manufacturers Start of Mass Production of Tocilizumab

2.9 Tocilizumab Market Competitive Analysis

2.9.1 Tocilizumab Market Concentration Rate (2021–2026)

2.9.2 Global 5 and 10 Largest Manufacturers by Tocilizumab Revenue in 2025

2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Tocilizumab revenue, 2025

2.10 Mergers & Acquisitions and Expansion

3 Segmentation Tocilizumab Market Classification

3.1 Introduction by Type

3.1.1 Min Purity Less Than 98%

3.1.2 Min Purity 98%-99%

3.1.3 Min Purity More Than 99%

3.1.4 Global Tocilizumab Sales Value by Type

3.1.4.1 Global Tocilizumab Sales Value by Type (2021 vs 2025 vs 2032)

3.1.4.2 Global Tocilizumab Sales Value, by Type (2021–2032)

3.1.4.3 Global Tocilizumab Sales Value, by Type (%), 2021–2032

3.1.5 Global Tocilizumab Sales Volume by Type

3.1.5.1 Global Tocilizumab Sales Volume by Type (2021 vs 2025 vs 2032)

3.1.5.2 Global Tocilizumab Sales Volume, by Type (2021–2032)

3.1.5.3 Global Tocilizumab Sales Volume, by Type (%), 2021–2032

3.1.6 Global Tocilizumab Average Price by Type (2021–2032)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Research

4.1.2 Medical

4.2 Global Tocilizumab Sales Value by Application

4.2.1 Global Tocilizumab Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Tocilizumab Sales Value, by Application (2021–2032)

4.2.3 Global Tocilizumab Sales Value, by Application (%), 2021–2032

4.3 Global Tocilizumab Sales Volume by Application

4.3.1 Global Tocilizumab Sales Volume by Application (2021 vs 2025 vs 2032)

4.3.2 Global Tocilizumab Sales Volume, by Application (2021–2032)

4.3.3 Global Tocilizumab Sales Volume, by Application (%), 2021–2032

4.4 Global Tocilizumab Average Price by Application (2021–2032)

5 Segmentation by Region

5.1 Global Tocilizumab Sales Value by Region

5.1.1 Global Tocilizumab Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Tocilizumab Sales Value by Region (2021–2026)

5.1.3 Global Tocilizumab Sales Value by Region (2027–2032)

5.1.4 Global Tocilizumab Sales Value by Region (%), 2021–2032

5.2 Global Tocilizumab Sales Volume by Region

5.2.1 Global Tocilizumab Sales Volume by Region: 2021 vs 2025 vs 2032

5.2.2 Global Tocilizumab Sales Volume by Region (2021–2026)

5.2.3 Global Tocilizumab Sales Volume by Region (2027–2032)

5.2.4 Global Tocilizumab Sales Volume by Region (%), 2021–2032

5.3 Global Tocilizumab Average Price by Region (2021–2032)

5.4 North America

5.4.1 North America Tocilizumab Sales Value, 2021–2032

5.4.2 North America Tocilizumab Sales Value by Country (%), 2025 vs 2032

5.5 Europe

5.5.1 Europe Tocilizumab Sales Value, 2021–2032

5.5.2 Europe Tocilizumab Sales Value by Country (%), 2025 vs 2032

5.6 Asia Pacific

5.6.1 Asia Pacific Tocilizumab Sales Value, 2021–2032

5.6.2 Asia Pacific Tocilizumab Sales Value by Region (%), 2025 vs 2032

5.7 South America

5.7.1 South America Tocilizumab Sales Value, 2021–2032

5.7.2 South America Tocilizumab Sales Value by Country (%), 2025 vs 2032

5.8 Middle East & Africa

5.8.1 Middle East & Africa Tocilizumab Sales Value, 2021–2032

5.8.2 Middle East & Africa Tocilizumab Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Tocilizumab Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Tocilizumab Sales Value and Sales Volume

6.2.1 Key Countries/Regions Tocilizumab Sales Value, 2021–2032

6.2.2 Key Countries/Regions Tocilizumab Sales Volume, 2021–2032

6.3 United States

6.3.1 United States Tocilizumab Sales Value, 2021–2032

6.3.2 United States Tocilizumab Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Tocilizumab Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Tocilizumab Sales Value, 2021–2032

6.4.2 Europe Tocilizumab Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Tocilizumab Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Tocilizumab Sales Value, 2021–2032

6.5.2 China Tocilizumab Sales Value by Type (%), 2025 vs 2032

6.5.3 China Tocilizumab Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Tocilizumab Sales Value, 2021–2032

6.6.2 Japan Tocilizumab Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Tocilizumab Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Tocilizumab Sales Value, 2021–2032

6.7.2 South Korea Tocilizumab Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Tocilizumab Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Tocilizumab Sales Value, 2021–2032

6.8.2 Southeast Asia Tocilizumab Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Tocilizumab Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Tocilizumab Sales Value, 2021–2032

6.9.2 India Tocilizumab Sales Value by Type (%), 2025 vs 2032

6.9.3 India Tocilizumab Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Bio-Rad Laboratories

7.1.1 Bio-Rad Laboratories Company Information

7.1.2 Bio-Rad Laboratories Introduction and Business Overview

7.1.3 Bio-Rad Laboratories Tocilizumab Sales, Revenue, Price and Gross Margin (2021–2026)

7.1.4 Bio-Rad Laboratories Tocilizumab Product Offerings

7.1.5 Bio-Rad Laboratories Recent Developments

7.2 Bio-Techne

7.2.1 Bio-Techne Company Information

7.2.2 Bio-Techne Introduction and Business Overview

7.2.3 Bio-Techne Tocilizumab Sales, Revenue, Price and Gross Margin (2021–2026)

7.2.4 Bio-Techne Tocilizumab Product Offerings

7.2.5 Bio-Techne Recent Developments

7.3 BioVision

7.3.1 BioVision Company Information

7.3.2 BioVision Introduction and Business Overview

7.3.3 BioVision Tocilizumab Sales, Revenue, Price and Gross Margin (2021–2026)

7.3.4 BioVision Tocilizumab Product Offerings

7.3.5 BioVision Recent Developments

7.4 Selleck Chemicals

7.4.1 Selleck Chemicals Company Information

7.4.2 Selleck Chemicals Introduction and Business Overview

7.4.3 Selleck Chemicals Tocilizumab Sales, Revenue, Price and Gross Margin (2021–2026)

7.4.4 Selleck Chemicals Tocilizumab Product Offerings

7.4.5 Selleck Chemicals Recent Developments

7.5 Biorbyt

7.5.1 Biorbyt Company Information

7.5.2 Biorbyt Introduction and Business Overview

7.5.3 Biorbyt Tocilizumab Sales, Revenue, Price and Gross Margin (2021–2026)

7.5.4 Biorbyt Tocilizumab Product Offerings

7.5.5 Biorbyt Recent Developments

7.6 AbMole

7.6.1 AbMole Company Information

7.6.2 AbMole Introduction and Business Overview

7.6.3 AbMole Tocilizumab Sales, Revenue, Price and Gross Margin (2021–2026)

7.6.4 AbMole Tocilizumab Product Offerings

7.6.5 AbMole Recent Developments

7.7 Biosynth Carbosynth

7.7.1 Biosynth Carbosynth Company Information

7.7.2 Biosynth Carbosynth Introduction and Business Overview

7.7.3 Biosynth Carbosynth Tocilizumab Sales, Revenue, Price and Gross Margin (2021–2026)

7.7.4 Biosynth Carbosynth Tocilizumab Product Offerings

7.7.5 Biosynth Carbosynth Recent Developments

7.8 SimSon Pharma

7.8.1 SimSon Pharma Company Information

7.8.2 SimSon Pharma Introduction and Business Overview

7.8.3 SimSon Pharma Tocilizumab Sales, Revenue, Price and Gross Margin (2021–2026)

7.8.4 SimSon Pharma Tocilizumab Product Offerings

7.8.5 SimSon Pharma Recent Developments

7.9 BOC Sciences

7.9.1 BOC Sciences Company Information

7.9.2 BOC Sciences Introduction and Business Overview

7.9.3 BOC Sciences Tocilizumab Sales, Revenue, Price and Gross Margin (2021–2026)

7.9.4 BOC Sciences Tocilizumab Product Offerings

7.9.5 BOC Sciences Recent Developments

7.10 Clearsynth

7.10.1 Clearsynth Company Information

7.10.2 Clearsynth Introduction and Business Overview

7.10.3 Clearsynth Tocilizumab Sales, Revenue, Price and Gross Margin (2021–2026)

7.10.4 Clearsynth Tocilizumab Product Offerings

7.10.5 Clearsynth Recent Developments

7.11 LifeSpan BioSciences

7.11.1 LifeSpan BioSciences Company Information

7.11.2 LifeSpan BioSciences Introduction and Business Overview

7.11.3 LifeSpan BioSciences Tocilizumab Sales, Revenue, Price and Gross Margin (2021–2026)

7.11.4 LifeSpan BioSciences Tocilizumab Product Offerings

7.11.5 LifeSpan BioSciences Recent Developments

8 Industry Chain Analysis

8.1 Tocilizumab Industrial Chain

8.2 Tocilizumab Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customer Analysis)

8.5 Sales Model and Sales Channelss

8.5.1 Tocilizumab Sales Model

8.5.2 Sales Channels

8.5.3 Tocilizumab Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Tocilizumab Market Trends

Table 2. Tocilizumab Market Drivers & Opportunities

Table 3. Tocilizumab Market Challenges

Table 4. Tocilizumab Market Restraints

Table 5. Global Tocilizumab Revenue by Company (US$ Million), 2021–2026

Table 6. Global Tocilizumab Revenue Market Share by Company (2021–2026)

Table 7. Global Tocilizumab Sales Volume by Company (Kg), 2021–2026

Table 8. Global Tocilizumab Sales Volume Market Share by Company (2021–2026)

Table 9. Global Market Tocilizumab Price by Company (K USD/Kg), 2021–2026

Table 10. Key Manufacturers Tocilizumab Manufacturing Base and Headquarters

Table 11. Key Manufacturers Tocilizumab Product Type

Table 12. Key Manufacturers Start of Mass Production of Tocilizumab

Table 13. Global Tocilizumab Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Tocilizumab revenue, 2025

Table 15. Mergers & Acquisitions and Expansion Plans

Table 16. Global Tocilizumab Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 17. Global Tocilizumab Sales Value by Type (US$ Million), 2021–2026

Table 18. Global Tocilizumab Sales Value by Type (US$ Million), 2027–2032

Table 19. Global Tocilizumab Sales Market Share in Value by Type (2021–2026)

Table 20. Global Tocilizumab Sales Market Share in Value by Type (2027–2032)

Table 21. Global Tocilizumab Sales Volume by Type: 2021 vs 2025 vs 2032 (Kg)

Table 22. Global Tocilizumab Sales Volume by Type (Kg), 2021–2026

Table 23. Global Tocilizumab Sales Volume by Type (Kg), 2027–2032

Table 24. Global Tocilizumab Sales Market Share in Volume by Type (2021–2026)

Table 25. Global Tocilizumab Sales Market Share in Volume by Type (2027–2032)

Table 26. Global Tocilizumab Price by Type (K USD/Kg), 2021–2026

Table 27. Global Tocilizumab Price by Type (K USD/Kg), 2027–2032

Table 28. Global Tocilizumab Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 29. Global Tocilizumab Sales Value by Application (US$ Million), 2021–2026

Table 30. Global Tocilizumab Sales Value by Application (US$ Million), 2027–2032

Table 31. Global Tocilizumab Sales Market Share in Value by Application (2021–2026)

Table 32. Global Tocilizumab Sales Market Share in Value by Application (2027–2032)

Table 33. Global Tocilizumab Sales Volume by Application: 2021 vs 2025 vs 2032 (Kg)

Table 34. Global Tocilizumab Sales Volume by Application (Kg), 2021–2026

Table 35. Global Tocilizumab Sales Volume by Application (Kg), 2027–2032

Table 36. Global Tocilizumab Sales Market Share in Volume by Application (2021–2026)

Table 37. Global Tocilizumab Sales Market Share in Volume by Application (2027–2032)

Table 38. Global Tocilizumab Price by Application (K USD/Kg), 2021–2026

Table 39. Global Tocilizumab Price by Application (K USD/Kg), 2027–2032

Table 40. Global Tocilizumab Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 41. Global Tocilizumab Sales Value by Region (US$ Million), 2021–2026

Table 42. Global Tocilizumab Sales Value by Region (US$ Million), 2027–2032

Table 43. Global Tocilizumab Sales Value by Region (%), 2021–2026

Table 44. Global Tocilizumab Sales Value by Region (%), 2027–2032

Table 45. Global Tocilizumab Sales Volume by Region (Kg): 2021 vs 2025 vs 2032

Table 46. Global Tocilizumab Sales Volume by Region (Kg), 2021–2026

Table 47. Global Tocilizumab Sales Volume by Region (Kg), 2027–2032

Table 48. Global Tocilizumab Sales Volume by Region (%), 2021–2026

Table 49. Global Tocilizumab Sales Volume by Region (%), 2027–2032

Table 50. Global Tocilizumab Average Price by Region (K USD/Kg), 2021–2026

Table 51. Global Tocilizumab Average Price by Region (K USD/Kg), 2027–2032

Table 52. Key Countries/Regions Tocilizumab Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 53. Key Countries/Regions Tocilizumab Sales Value, (US$ Million), 2021–2026

Table 54. Key Countries/Regions Tocilizumab Sales Value, (US$ Million), 2027–2032

Table 55. Key Countries/Regions Tocilizumab Sales Volume, (Kg), 2021–2026

Table 56. Key Countries/Regions Tocilizumab Sales Volume, (Kg), 2027–2032

Table 57. Bio-Rad Laboratories Company Information

Table 58. Bio-Rad Laboratories Introduction and Business Overview

Table 59. Bio-Rad Laboratories Tocilizumab Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2021–2026)

Table 60. Bio-Rad Laboratories Tocilizumab Product Offerings

Table 61. Bio-Rad Laboratories Recent Developments

Table 62. Bio-Techne Company Information

Table 63. Bio-Techne Introduction and Business Overview

Table 64. Bio-Techne Tocilizumab Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2021–2026)

Table 65. Bio-Techne Tocilizumab Product Offerings

Table 66. Bio-Techne Recent Developments

Table 67. BioVision Company Information

Table 68. BioVision Introduction and Business Overview

Table 69. BioVision Tocilizumab Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2021–2026)

Table 70. BioVision Tocilizumab Product Offerings

Table 71. BioVision Recent Developments

Table 72. Selleck Chemicals Company Information

Table 73. Selleck Chemicals Introduction and Business Overview

Table 74. Selleck Chemicals Tocilizumab Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2021–2026)

Table 75. Selleck Chemicals Tocilizumab Product Offerings

Table 76. Selleck Chemicals Recent Developments

Table 77. Biorbyt Company Information

Table 78. Biorbyt Introduction and Business Overview

Table 79. Biorbyt Tocilizumab Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2021–2026)

Table 80. Biorbyt Tocilizumab Product Offerings

Table 81. Biorbyt Recent Developments

Table 82. AbMole Company Information

Table 83. AbMole Introduction and Business Overview

Table 84. AbMole Tocilizumab Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2021–2026)

Table 85. AbMole Tocilizumab Product Offerings

Table 86. AbMole Recent Developments

Table 87. Biosynth Carbosynth Company Information

Table 88. Biosynth Carbosynth Introduction and Business Overview

Table 89. Biosynth Carbosynth Tocilizumab Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2021–2026)

Table 90. Biosynth Carbosynth Tocilizumab Product Offerings

Table 91. Biosynth Carbosynth Recent Developments

Table 92. SimSon Pharma Company Information

Table 93. SimSon Pharma Introduction and Business Overview

Table 94. SimSon Pharma Tocilizumab Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2021–2026)

Table 95. SimSon Pharma Tocilizumab Product Offerings

Table 96. SimSon Pharma Recent Developments

Table 97. BOC Sciences Company Information

Table 98. BOC Sciences Introduction and Business Overview

Table 99. BOC Sciences Tocilizumab Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2021–2026)

Table 100. BOC Sciences Tocilizumab Product Offerings

Table 101. BOC Sciences Recent Developments

Table 102. Clearsynth Company Information

Table 103. Clearsynth Introduction and Business Overview

Table 104. Clearsynth Tocilizumab Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2021–2026)

Table 105. Clearsynth Tocilizumab Product Offerings

Table 106. Clearsynth Recent Developments

Table 107. LifeSpan BioSciences Company Information

Table 108. LifeSpan BioSciences Introduction and Business Overview

Table 109. LifeSpan BioSciences Tocilizumab Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2021–2026)

Table 110. LifeSpan BioSciences Tocilizumab Product Offerings

Table 111. LifeSpan BioSciences Recent Developments

Table 112. Key Raw Materials Lists

Table 113. Key Suppliers of Raw Materials Lists

Table 114. Tocilizumab Downstream Customers

Table 115. Tocilizumab Distributors List

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

List of Figures

Figure 1. Tocilizumab Product Picture

Figure 2. Global Tocilizumab Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Tocilizumab Sales Value (US$ Million), 2021–2032

Figure 4. Global Tocilizumab Sales Volume (Kg), 2021–2032

Figure 5. Global Tocilizumab Sales Price (K USD/Kg), 2021–2032

Figure 6. Tocilizumab Report Years Considered

Figure 7. Global Tocilizumab Players Revenue Ranking (US$ Million), 2025

Figure 8. Global Tocilizumab Sales Volume Ranking of Players (Kg), 2025

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Tocilizumab Revenue in 2025

Figure 10. Tocilizumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 11. Min Purity Less Than 98% Picture

Figure 12. Min Purity 98%-99% Picture

Figure 13. Min Purity More Than 99% Picture

Figure 14. Global Tocilizumab Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Tocilizumab Sales Value Market Share by Type, 2025 & 2032

Figure 16. Global Tocilizumab Sales Volume by Type (Kg), 2021 vs 2025 vs 2032

Figure 17. Global Tocilizumab Sales Volume Market Share by Type, 2025 & 2032

Figure 18. Global Tocilizumab Price by Type (K USD/Kg), 2021–2032

Figure 19. Product Picture of Research

Figure 20. Product Picture of Medical

Figure 21. Global Tocilizumab Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 22. Global Tocilizumab Sales Value Market Share by Application, 2025 & 2032

Figure 23. Global Tocilizumab Sales Volume by Application (Kg), 2021 vs 2025 vs 2032

Figure 24. Global Tocilizumab Sales Volume Market Share by Application, 2025 & 2032

Figure 25. Global Tocilizumab Price by Application (K USD/Kg), 2021–2032

Figure 26. North America Tocilizumab Sales Value (US$ Million), 2021–2032

Figure 27. North America Tocilizumab Sales Value by Country (%), 2025 vs 2032

Figure 28. Europe Tocilizumab Sales Value (US$ Million), 2021–2032

Figure 29. Europe Tocilizumab Sales Value by Country (%), 2025 vs 2032

Figure 30. Asia Pacific Tocilizumab Sales Value (US$ Million), 2021–2032

Figure 31. Asia Pacific Tocilizumab Sales Value by Region (%), 2025 vs 2032

Figure 32. South America Tocilizumab Sales Value (US$ Million), 2021–2032

Figure 33. South America Tocilizumab Sales Value by Country (%), 2025 vs 2032

Figure 34. Middle East & Africa Tocilizumab Sales Value (US$ Million), 2021–2032

Figure 35. Middle East & Africa Tocilizumab Sales Value by Country (%), 2025 vs 2032

Figure 36. Key Countries/Regions Tocilizumab Sales Value (%), 2021–2032

Figure 37. Key Countries/Regions Tocilizumab Sales Volume (%), 2021–2032

Figure 38. United States Tocilizumab Sales Value (US$ Million), 2021–2032

Figure 39. United States Tocilizumab Sales Value by Type (%), 2025 vs 2032

Figure 40. United States Tocilizumab Sales Value by Application (%), 2025 vs 2032

Figure 41. Europe Tocilizumab Sales Value (US$ Million), 2021–2032

Figure 42. Europe Tocilizumab Sales Value by Type (%), 2025 vs 2032

Figure 43. Europe Tocilizumab Sales Value by Application (%), 2025 vs 2032

Figure 44. China Tocilizumab Sales Value (US$ Million), 2021–2032

Figure 45. China Tocilizumab Sales Value by Type (%), 2025 vs 2032

Figure 46. China Tocilizumab Sales Value by Application (%), 2025 vs 2032

Figure 47. Japan Tocilizumab Sales Value (US$ Million), 2021–2032

Figure 48. Japan Tocilizumab Sales Value by Type (%), 2025 vs 2032

Figure 49. Japan Tocilizumab Sales Value by Application (%), 2025 vs 2032

Figure 50. South Korea Tocilizumab Sales Value (US$ Million), 2021–2032

Figure 51. South Korea Tocilizumab Sales Value by Type (%), 2025 vs 2032

Figure 52. South Korea Tocilizumab Sales Value by Application (%), 2025 vs 2032

Figure 53. Southeast Asia Tocilizumab Sales Value (US$ Million), 2021–2032

Figure 54. Southeast Asia Tocilizumab Sales Value by Type (%), 2025 vs 2032

Figure 55. Southeast Asia Tocilizumab Sales Value by Application (%), 2025 vs 2032

Figure 56. India Tocilizumab Sales Value (US$ Million), 2021–2032

Figure 57. India Tocilizumab Sales Value by Type (%), 2025 vs 2032

Figure 58. India Tocilizumab Sales Value by Application (%), 2025 vs 2032

Figure 59. Tocilizumab Industrial Chain

Figure 60. Tocilizumab Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Tocilizumab market? zhanKai

The top companies in the global Tocilizumab market are Bio-Rad Laboratories、Bio-Techne、BioVision.

Related Reports

Global Tocilizumab Market Research Report 2026
The global Tocilizumab market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 143
USD 2900.00
(Single User License)
Global Tocilizumab Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Tocilizumab market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 152
USD 4900.00
(Single User License)
Tocilizumab- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tocilizumab was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 115
USD 3950.00
(Single User License)
Global Tocilizumab Market Research Report 2025
The global market for Tocilizumab was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 99
USD 2900.00
(Single User License)
Global Tocilizumab Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Tocilizumab market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 93
USD 4250.00
(Single User License)
Global Tocilizumab Market Insights, Forecast to 2030
Tocilizumab is a humanized monoclonal antibody resistant against the interleukin-6 receptor (IL-6R). It is an immunosuppressive agent commonly used for the treatment of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis.
Published Date: 2024-04-07
Pages: 105
USD 4900.00
(Single User License)
Tocilizumab - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Tocilizumab is a humanized monoclonal antibody resistant against the interleukin-6 receptor (IL-6R). It is an immunosuppressive agent commonly used for the treatment of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis.
Published Date: 2024-02-19
Pages: 121
USD 3950.00
(Single User License)
Global Tocilizumab Market Research Report 2024
Tocilizumab is a humanized monoclonal antibody resistant against the interleukin-6 receptor (IL-6R). It is an immunosuppressive agent commonly used for the treatment of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis.
Published Date: 2024-01-12
Pages: 102
USD 2900.00
(Single User License)

Global Tocilizumab Market Research Report 2026
The global Tocilizumab market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 143
USD 2900.00 (Single User License)
Global Tocilizumab Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Tocilizumab market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 152
USD 4900.00 (Single User License)
Tocilizumab- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tocilizumab was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 115
USD 3950.00 (Single User License)
Global Tocilizumab Market Research Report 2025
The global market for Tocilizumab was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 99
USD 2900.00 (Single User License)
Global Tocilizumab Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Tocilizumab market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 93
USD 4250.00 (Single User License)
Global Tocilizumab Market Insights, Forecast to 2030
Tocilizumab is a humanized monoclonal antibody resistant against the interleukin-6 receptor (IL-6R). It is an immunosuppressive agent commonly used for the treatment of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis.
Published: 2024-04-07
Pages: 105
USD 4900.00 (Single User License)
Tocilizumab - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Tocilizumab is a humanized monoclonal antibody resistant against the interleukin-6 receptor (IL-6R). It is an immunosuppressive agent commonly used for the treatment of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis.
Published: 2024-02-19
Pages: 121
USD 3950.00 (Single User License)
Global Tocilizumab Market Research Report 2024
Tocilizumab is a humanized monoclonal antibody resistant against the interleukin-6 receptor (IL-6R). It is an immunosuppressive agent commonly used for the treatment of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis.
Published: 2024-01-12
Pages: 102
USD 2900.00 (Single User License)